nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Renal failure—Doxorubicin—bone cancer	0.000431	0.000431	CcSEcCtD
Pregabalin—Erythema multiforme—Methotrexate—bone cancer	0.00043	0.00043	CcSEcCtD
Pregabalin—Neuropathy peripheral—Doxorubicin—bone cancer	0.00043	0.00043	CcSEcCtD
Pregabalin—Haemoglobin—Epirubicin—bone cancer	0.000428	0.000428	CcSEcCtD
Pregabalin—Stomatitis—Doxorubicin—bone cancer	0.000428	0.000428	CcSEcCtD
Pregabalin—Jaundice—Doxorubicin—bone cancer	0.000428	0.000428	CcSEcCtD
Pregabalin—Rhinitis—Epirubicin—bone cancer	0.000427	0.000427	CcSEcCtD
Pregabalin—Urinary tract infection—Doxorubicin—bone cancer	0.000427	0.000427	CcSEcCtD
Pregabalin—Conjunctivitis—Doxorubicin—bone cancer	0.000427	0.000427	CcSEcCtD
Pregabalin—Haemorrhage—Epirubicin—bone cancer	0.000426	0.000426	CcSEcCtD
Pregabalin—Hepatitis—Epirubicin—bone cancer	0.000426	0.000426	CcSEcCtD
Pregabalin—Eye disorder—Methotrexate—bone cancer	0.000425	0.000425	CcSEcCtD
Pregabalin—Tinnitus—Methotrexate—bone cancer	0.000424	0.000424	CcSEcCtD
Pregabalin—Hypoaesthesia—Epirubicin—bone cancer	0.000424	0.000424	CcSEcCtD
Pregabalin—Asthenia—Cisplatin—bone cancer	0.000423	0.000423	CcSEcCtD
Pregabalin—Pharyngitis—Epirubicin—bone cancer	0.000423	0.000423	CcSEcCtD
Pregabalin—Cardiac disorder—Methotrexate—bone cancer	0.000422	0.000422	CcSEcCtD
Pregabalin—Sweating—Doxorubicin—bone cancer	0.000421	0.000421	CcSEcCtD
Pregabalin—Urinary tract disorder—Epirubicin—bone cancer	0.00042	0.00042	CcSEcCtD
Pregabalin—Oedema peripheral—Epirubicin—bone cancer	0.000419	0.000419	CcSEcCtD
Pregabalin—Haematuria—Doxorubicin—bone cancer	0.000418	0.000418	CcSEcCtD
Pregabalin—Connective tissue disorder—Epirubicin—bone cancer	0.000418	0.000418	CcSEcCtD
Pregabalin—Urethral disorder—Epirubicin—bone cancer	0.000417	0.000417	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—bone cancer	0.000414	0.000414	CcSEcCtD
Pregabalin—Angiopathy—Methotrexate—bone cancer	0.000413	0.000413	CcSEcCtD
Pregabalin—Sinusitis—Doxorubicin—bone cancer	0.000412	0.000412	CcSEcCtD
Pregabalin—Immune system disorder—Methotrexate—bone cancer	0.000411	0.000411	CcSEcCtD
Pregabalin—Visual impairment—Epirubicin—bone cancer	0.00041	0.00041	CcSEcCtD
Pregabalin—Mediastinal disorder—Methotrexate—bone cancer	0.00041	0.00041	CcSEcCtD
Pregabalin—Chills—Methotrexate—bone cancer	0.000408	0.000408	CcSEcCtD
Pregabalin—Diarrhoea—Cisplatin—bone cancer	0.000403	0.000403	CcSEcCtD
Pregabalin—Erythema multiforme—Epirubicin—bone cancer	0.000403	0.000403	CcSEcCtD
Pregabalin—Alopecia—Methotrexate—bone cancer	0.000402	0.000402	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—bone cancer	0.000401	0.000401	CcSEcCtD
Pregabalin—Mental disorder—Methotrexate—bone cancer	0.000399	0.000399	CcSEcCtD
Pregabalin—Eye disorder—Epirubicin—bone cancer	0.000398	0.000398	CcSEcCtD
Pregabalin—Tinnitus—Epirubicin—bone cancer	0.000397	0.000397	CcSEcCtD
Pregabalin—Malnutrition—Methotrexate—bone cancer	0.000396	0.000396	CcSEcCtD
Pregabalin—Haemoglobin—Doxorubicin—bone cancer	0.000396	0.000396	CcSEcCtD
Pregabalin—Flushing—Epirubicin—bone cancer	0.000395	0.000395	CcSEcCtD
Pregabalin—Cardiac disorder—Epirubicin—bone cancer	0.000395	0.000395	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—bone cancer	0.000395	0.000395	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—bone cancer	0.000394	0.000394	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—bone cancer	0.000394	0.000394	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—bone cancer	0.000392	0.000392	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—bone cancer	0.000391	0.000391	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—bone cancer	0.000389	0.000389	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—bone cancer	0.000388	0.000388	CcSEcCtD
Pregabalin—Dysgeusia—Methotrexate—bone cancer	0.000388	0.000388	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—bone cancer	0.000387	0.000387	CcSEcCtD
Pregabalin—Angiopathy—Epirubicin—bone cancer	0.000386	0.000386	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—bone cancer	0.000386	0.000386	CcSEcCtD
Pregabalin—Immune system disorder—Epirubicin—bone cancer	0.000385	0.000385	CcSEcCtD
Pregabalin—Mediastinal disorder—Epirubicin—bone cancer	0.000384	0.000384	CcSEcCtD
Pregabalin—Back pain—Methotrexate—bone cancer	0.000383	0.000383	CcSEcCtD
Pregabalin—Chills—Epirubicin—bone cancer	0.000382	0.000382	CcSEcCtD
Pregabalin—Arrhythmia—Epirubicin—bone cancer	0.00038	0.00038	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—bone cancer	0.00038	0.00038	CcSEcCtD
Pregabalin—Alopecia—Epirubicin—bone cancer	0.000376	0.000376	CcSEcCtD
Pregabalin—Vomiting—Cisplatin—bone cancer	0.000374	0.000374	CcSEcCtD
Pregabalin—Vision blurred—Methotrexate—bone cancer	0.000373	0.000373	CcSEcCtD
Pregabalin—Mental disorder—Epirubicin—bone cancer	0.000373	0.000373	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—bone cancer	0.000372	0.000372	CcSEcCtD
Pregabalin—Rash—Cisplatin—bone cancer	0.000371	0.000371	CcSEcCtD
Pregabalin—Dermatitis—Cisplatin—bone cancer	0.000371	0.000371	CcSEcCtD
Pregabalin—Malnutrition—Epirubicin—bone cancer	0.000371	0.000371	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—bone cancer	0.000368	0.000368	CcSEcCtD
Pregabalin—Ill-defined disorder—Methotrexate—bone cancer	0.000367	0.000367	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—bone cancer	0.000367	0.000367	CcSEcCtD
Pregabalin—Anaemia—Methotrexate—bone cancer	0.000366	0.000366	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—bone cancer	0.000366	0.000366	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—bone cancer	0.000366	0.000366	CcSEcCtD
Pregabalin—Flatulence—Epirubicin—bone cancer	0.000365	0.000365	CcSEcCtD
Pregabalin—Tension—Epirubicin—bone cancer	0.000364	0.000364	CcSEcCtD
Pregabalin—Dysgeusia—Epirubicin—bone cancer	0.000363	0.000363	CcSEcCtD
Pregabalin—Nervousness—Epirubicin—bone cancer	0.00036	0.00036	CcSEcCtD
Pregabalin—Back pain—Epirubicin—bone cancer	0.000358	0.000358	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—bone cancer	0.000357	0.000357	CcSEcCtD
Pregabalin—Malaise—Methotrexate—bone cancer	0.000357	0.000357	CcSEcCtD
Pregabalin—Muscle spasms—Epirubicin—bone cancer	0.000356	0.000356	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—bone cancer	0.000356	0.000356	CcSEcCtD
Pregabalin—Vertigo—Methotrexate—bone cancer	0.000356	0.000356	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—bone cancer	0.000355	0.000355	CcSEcCtD
Pregabalin—Leukopenia—Methotrexate—bone cancer	0.000354	0.000354	CcSEcCtD
Pregabalin—Chills—Doxorubicin—bone cancer	0.000353	0.000353	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—bone cancer	0.000352	0.000352	CcSEcCtD
Pregabalin—Nausea—Cisplatin—bone cancer	0.00035	0.00035	CcSEcCtD
Pregabalin—Vision blurred—Epirubicin—bone cancer	0.000349	0.000349	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—bone cancer	0.000348	0.000348	CcSEcCtD
Pregabalin—Cough—Methotrexate—bone cancer	0.000346	0.000346	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—bone cancer	0.000345	0.000345	CcSEcCtD
Pregabalin—Ill-defined disorder—Epirubicin—bone cancer	0.000344	0.000344	CcSEcCtD
Pregabalin—Convulsion—Methotrexate—bone cancer	0.000343	0.000343	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—bone cancer	0.000343	0.000343	CcSEcCtD
Pregabalin—Anaemia—Epirubicin—bone cancer	0.000343	0.000343	CcSEcCtD
Pregabalin—Agitation—Epirubicin—bone cancer	0.000341	0.000341	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—bone cancer	0.000338	0.000338	CcSEcCtD
Pregabalin—Myalgia—Methotrexate—bone cancer	0.000337	0.000337	CcSEcCtD
Pregabalin—Chest pain—Methotrexate—bone cancer	0.000337	0.000337	CcSEcCtD
Pregabalin—Arthralgia—Methotrexate—bone cancer	0.000337	0.000337	CcSEcCtD
Pregabalin—Tension—Doxorubicin—bone cancer	0.000336	0.000336	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—bone cancer	0.000336	0.000336	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000335	0.000335	CcSEcCtD
Pregabalin—Malaise—Epirubicin—bone cancer	0.000334	0.000334	CcSEcCtD
Pregabalin—Discomfort—Methotrexate—bone cancer	0.000333	0.000333	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—bone cancer	0.000333	0.000333	CcSEcCtD
Pregabalin—Vertigo—Epirubicin—bone cancer	0.000333	0.000333	CcSEcCtD
Pregabalin—Syncope—Epirubicin—bone cancer	0.000332	0.000332	CcSEcCtD
Pregabalin—Leukopenia—Epirubicin—bone cancer	0.000332	0.000332	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—bone cancer	0.000332	0.000332	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—bone cancer	0.00033	0.00033	CcSEcCtD
Pregabalin—Palpitations—Epirubicin—bone cancer	0.000327	0.000327	CcSEcCtD
Pregabalin—Confusional state—Methotrexate—bone cancer	0.000326	0.000326	CcSEcCtD
Pregabalin—Loss of consciousness—Epirubicin—bone cancer	0.000326	0.000326	CcSEcCtD
Pregabalin—Cough—Epirubicin—bone cancer	0.000323	0.000323	CcSEcCtD
Pregabalin—Anaphylactic shock—Methotrexate—bone cancer	0.000323	0.000323	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—bone cancer	0.000323	0.000323	CcSEcCtD
Pregabalin—Convulsion—Epirubicin—bone cancer	0.000321	0.000321	CcSEcCtD
Pregabalin—Infection—Methotrexate—bone cancer	0.000321	0.000321	CcSEcCtD
Pregabalin—Hypertension—Epirubicin—bone cancer	0.00032	0.00032	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—bone cancer	0.000318	0.000318	CcSEcCtD
Pregabalin—Nervous system disorder—Methotrexate—bone cancer	0.000317	0.000317	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—bone cancer	0.000317	0.000317	CcSEcCtD
Pregabalin—Thrombocytopenia—Methotrexate—bone cancer	0.000316	0.000316	CcSEcCtD
Pregabalin—Chest pain—Epirubicin—bone cancer	0.000316	0.000316	CcSEcCtD
Pregabalin—Myalgia—Epirubicin—bone cancer	0.000316	0.000316	CcSEcCtD
Pregabalin—Arthralgia—Epirubicin—bone cancer	0.000316	0.000316	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—bone cancer	0.000315	0.000315	CcSEcCtD
Pregabalin—Anxiety—Epirubicin—bone cancer	0.000314	0.000314	CcSEcCtD
Pregabalin—Skin disorder—Methotrexate—bone cancer	0.000314	0.000314	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000313	0.000313	CcSEcCtD
Pregabalin—Hyperhidrosis—Methotrexate—bone cancer	0.000312	0.000312	CcSEcCtD
Pregabalin—Discomfort—Epirubicin—bone cancer	0.000312	0.000312	CcSEcCtD
Pregabalin—Malaise—Doxorubicin—bone cancer	0.000309	0.000309	CcSEcCtD
Pregabalin—Dry mouth—Epirubicin—bone cancer	0.000309	0.000309	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—bone cancer	0.000308	0.000308	CcSEcCtD
Pregabalin—Anorexia—Methotrexate—bone cancer	0.000308	0.000308	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—bone cancer	0.000308	0.000308	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—bone cancer	0.000307	0.000307	CcSEcCtD
Pregabalin—Confusional state—Epirubicin—bone cancer	0.000305	0.000305	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—bone cancer	0.000303	0.000303	CcSEcCtD
Pregabalin—Oedema—Epirubicin—bone cancer	0.000302	0.000302	CcSEcCtD
Pregabalin—Anaphylactic shock—Epirubicin—bone cancer	0.000302	0.000302	CcSEcCtD
Pregabalin—Hypotension—Methotrexate—bone cancer	0.000302	0.000302	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—bone cancer	0.000301	0.000301	CcSEcCtD
Pregabalin—Infection—Epirubicin—bone cancer	0.0003	0.0003	CcSEcCtD
Pregabalin—Cough—Doxorubicin—bone cancer	0.000299	0.000299	CcSEcCtD
Pregabalin—Shock—Epirubicin—bone cancer	0.000298	0.000298	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—bone cancer	0.000297	0.000297	CcSEcCtD
Pregabalin—Nervous system disorder—Epirubicin—bone cancer	0.000297	0.000297	CcSEcCtD
Pregabalin—Thrombocytopenia—Epirubicin—bone cancer	0.000296	0.000296	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—bone cancer	0.000296	0.000296	CcSEcCtD
Pregabalin—Tachycardia—Epirubicin—bone cancer	0.000295	0.000295	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000294	0.000294	CcSEcCtD
Pregabalin—Skin disorder—Epirubicin—bone cancer	0.000294	0.000294	CcSEcCtD
Pregabalin—Hyperhidrosis—Epirubicin—bone cancer	0.000292	0.000292	CcSEcCtD
Pregabalin—Insomnia—Methotrexate—bone cancer	0.000292	0.000292	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—bone cancer	0.000292	0.000292	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—bone cancer	0.000292	0.000292	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—bone cancer	0.000292	0.000292	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—bone cancer	0.000291	0.000291	CcSEcCtD
Pregabalin—Paraesthesia—Methotrexate—bone cancer	0.00029	0.00029	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00029	0.00029	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—bone cancer	0.000288	0.000288	CcSEcCtD
Pregabalin—Anorexia—Epirubicin—bone cancer	0.000288	0.000288	CcSEcCtD
Pregabalin—Dyspnoea—Methotrexate—bone cancer	0.000288	0.000288	CcSEcCtD
Pregabalin—Somnolence—Methotrexate—bone cancer	0.000287	0.000287	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—bone cancer	0.000286	0.000286	CcSEcCtD
Pregabalin—Hypotension—Epirubicin—bone cancer	0.000283	0.000283	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—bone cancer	0.000282	0.000282	CcSEcCtD
Pregabalin—Decreased appetite—Methotrexate—bone cancer	0.000281	0.000281	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—bone cancer	0.00028	0.00028	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—bone cancer	0.00028	0.00028	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000279	0.000279	CcSEcCtD
Pregabalin—Fatigue—Methotrexate—bone cancer	0.000279	0.000279	CcSEcCtD
Pregabalin—Infection—Doxorubicin—bone cancer	0.000278	0.000278	CcSEcCtD
Pregabalin—Pain—Methotrexate—bone cancer	0.000276	0.000276	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000276	0.000276	CcSEcCtD
Pregabalin—Shock—Doxorubicin—bone cancer	0.000275	0.000275	CcSEcCtD
Pregabalin—Nervous system disorder—Doxorubicin—bone cancer	0.000274	0.000274	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—bone cancer	0.000274	0.000274	CcSEcCtD
Pregabalin—Insomnia—Epirubicin—bone cancer	0.000274	0.000274	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—bone cancer	0.000273	0.000273	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—bone cancer	0.000272	0.000272	CcSEcCtD
Pregabalin—Paraesthesia—Epirubicin—bone cancer	0.000272	0.000272	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—bone cancer	0.000271	0.000271	CcSEcCtD
Pregabalin—Dyspnoea—Epirubicin—bone cancer	0.00027	0.00027	CcSEcCtD
Pregabalin—Somnolence—Epirubicin—bone cancer	0.000269	0.000269	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—bone cancer	0.000267	0.000267	CcSEcCtD
Pregabalin—Feeling abnormal—Methotrexate—bone cancer	0.000266	0.000266	CcSEcCtD
Pregabalin—Gastrointestinal pain—Methotrexate—bone cancer	0.000264	0.000264	CcSEcCtD
Pregabalin—Decreased appetite—Epirubicin—bone cancer	0.000263	0.000263	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—bone cancer	0.000261	0.000261	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000261	0.000261	CcSEcCtD
Pregabalin—Fatigue—Epirubicin—bone cancer	0.000261	0.000261	CcSEcCtD
Pregabalin—Constipation—Epirubicin—bone cancer	0.000259	0.000259	CcSEcCtD
Pregabalin—Pain—Epirubicin—bone cancer	0.000259	0.000259	CcSEcCtD
Pregabalin—Urticaria—Methotrexate—bone cancer	0.000257	0.000257	CcSEcCtD
Pregabalin—Body temperature increased—Methotrexate—bone cancer	0.000255	0.000255	CcSEcCtD
Pregabalin—Abdominal pain—Methotrexate—bone cancer	0.000255	0.000255	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000255	0.000255	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—bone cancer	0.000253	0.000253	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—bone cancer	0.000251	0.000251	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—bone cancer	0.000249	0.000249	CcSEcCtD
Pregabalin—Feeling abnormal—Epirubicin—bone cancer	0.000249	0.000249	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—bone cancer	0.000249	0.000249	CcSEcCtD
Pregabalin—Gastrointestinal pain—Epirubicin—bone cancer	0.000247	0.000247	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—bone cancer	0.000243	0.000243	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000242	0.000242	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—bone cancer	0.000241	0.000241	CcSEcCtD
Pregabalin—Urticaria—Epirubicin—bone cancer	0.00024	0.00024	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—bone cancer	0.000239	0.000239	CcSEcCtD
Pregabalin—Pain—Doxorubicin—bone cancer	0.000239	0.000239	CcSEcCtD
Pregabalin—Abdominal pain—Epirubicin—bone cancer	0.000239	0.000239	CcSEcCtD
Pregabalin—Body temperature increased—Epirubicin—bone cancer	0.000239	0.000239	CcSEcCtD
Pregabalin—Hypersensitivity—Methotrexate—bone cancer	0.000238	0.000238	CcSEcCtD
Pregabalin—Asthenia—Methotrexate—bone cancer	0.000232	0.000232	CcSEcCtD
Pregabalin—Feeling abnormal—Doxorubicin—bone cancer	0.000231	0.000231	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000229	0.000229	CcSEcCtD
Pregabalin—Pruritus—Methotrexate—bone cancer	0.000229	0.000229	CcSEcCtD
Pregabalin—Hypersensitivity—Epirubicin—bone cancer	0.000223	0.000223	CcSEcCtD
Pregabalin—Urticaria—Doxorubicin—bone cancer	0.000222	0.000222	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—bone cancer	0.000221	0.000221	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—bone cancer	0.000221	0.000221	CcSEcCtD
Pregabalin—Diarrhoea—Methotrexate—bone cancer	0.000221	0.000221	CcSEcCtD
Pregabalin—Asthenia—Epirubicin—bone cancer	0.000217	0.000217	CcSEcCtD
Pregabalin—Pruritus—Epirubicin—bone cancer	0.000214	0.000214	CcSEcCtD
Pregabalin—Dizziness—Methotrexate—bone cancer	0.000214	0.000214	CcSEcCtD
Pregabalin—Diarrhoea—Epirubicin—bone cancer	0.000207	0.000207	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—bone cancer	0.000206	0.000206	CcSEcCtD
Pregabalin—Vomiting—Methotrexate—bone cancer	0.000205	0.000205	CcSEcCtD
Pregabalin—Rash—Methotrexate—bone cancer	0.000204	0.000204	CcSEcCtD
Pregabalin—Dermatitis—Methotrexate—bone cancer	0.000204	0.000204	CcSEcCtD
Pregabalin—Headache—Methotrexate—bone cancer	0.000202	0.000202	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—bone cancer	0.000201	0.000201	CcSEcCtD
Pregabalin—Dizziness—Epirubicin—bone cancer	0.0002	0.0002	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—bone cancer	0.000198	0.000198	CcSEcCtD
Pregabalin—Vomiting—Epirubicin—bone cancer	0.000192	0.000192	CcSEcCtD
Pregabalin—Nausea—Methotrexate—bone cancer	0.000192	0.000192	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—bone cancer	0.000191	0.000191	CcSEcCtD
Pregabalin—Rash—Epirubicin—bone cancer	0.000191	0.000191	CcSEcCtD
Pregabalin—Dermatitis—Epirubicin—bone cancer	0.000191	0.000191	CcSEcCtD
Pregabalin—Headache—Epirubicin—bone cancer	0.000189	0.000189	CcSEcCtD
Pregabalin—Dizziness—Doxorubicin—bone cancer	0.000185	0.000185	CcSEcCtD
Pregabalin—Nausea—Epirubicin—bone cancer	0.00018	0.00018	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—bone cancer	0.000178	0.000178	CcSEcCtD
Pregabalin—Rash—Doxorubicin—bone cancer	0.000176	0.000176	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—bone cancer	0.000176	0.000176	CcSEcCtD
Pregabalin—Headache—Doxorubicin—bone cancer	0.000175	0.000175	CcSEcCtD
Pregabalin—Nausea—Doxorubicin—bone cancer	0.000166	0.000166	CcSEcCtD
